$CELG News Celgene shares up on news of positive

New Post Public Reply Private Reply Replies (0) Message Board

Sep 4, 2014 at 12:03 PM

$CELG News

Celgene shares up on news of positive late-stage drug trial 7:42 a.m. Today - Ciara Linnane
How retail sector sets up stocks at the end of summer 3:32 p.m. Aug. 14, 2014 - The Trading Deck
S&P 500 retests the breakdown point 11:17 a.m. Aug. 14, 2014 - Michael Ashbaugh
S&P 500 ekes out another record close: stock market live blog recap 4:03 p.m. July 24, 2014 - blogs.marketwatch.com
Biotechs beat estimates, but the Street wants more 11:44 a.m. July 24, 2014 - Russ Britt
Biogen results crush consensus 4:55 p.m. July 23, 2014 - The Trading Deck
Nasdaq needs to turn up the volume 11:59 a.m. July 17, 2014 - The Trading Deck
Bull rolls on, but opportunities start to dwindle 1:52 p.m. July 10, 2014 - The Trading Deck
Reynolds rises on buyout report; Delta gains altitude 2:25 p.m. July 9, 2014 - Sue Chang
Celgene's arthritis drug fails a test, but company's stock rises anyway 1:23 p.m. July 9, 2014 - Russ Britt
Celgene shares slump as late-stage trial misses goal 7:27 a.m. July 9, 2014 - Ciara Linnane
S&P, Dow rattle cage on uncharted territory 11:20 a.m. July 1, 2014 - Michael Ashbaugh
S&P, Dow rattle cage on uncharted territory 10:54 a.m. July 1, 2014 - Michael Ashbaugh
Celgene's fourth stock split is a hit with investors as shares climb 1:02 p.m. June 19, 2014 - Russ Britt
Celgene shareholders approve 2-for-1 stock split 8:57 a.m. June 19, 2014 - Ciara Linnane
Celgene to increase buyback program to 1.15 bln shares from 575 mln 8:52 a.m. June 19, 2014 - Ciara Linnane
Celgene shareholders approve 2-for-1 stock split 8:51 a.m. June 19, 2014 - Ciara Linnane
Celgene drops 1.9%, among worst S&P 500 losers 9:32 a.m. May 29, 2014 - Sue Chang
Higher rates are coming — here’s how you prepare 8:38 a.m. May 12, 2014 - Jeff Reeves
Wall Street up for second day on earnings cheer; biotechs rebound: Stock market live blog recap 4:03 p.m. April 29, 2014 - blogs.marketwatch.com

Three Stocks Top-Performing Funds Like: Facebook Baidu Gilead 5:28 p.m. Sept. 3, 2014 - Investors Business Daily
Determining Celgene's Fair Value 11:24 a.m. Sept. 3, 2014 - Seeking Alpha
Bristol-Myers Returns Clazakizumab Rights, Alder Sinks - Analyst Blog 11:02 a.m. Sept. 3, 2014 - Zacks.com
Cramer's Mad Money - Fascinating Schisms (9/2/14) 6:17 a.m. Sept. 3, 2014 - Seeking Alpha
Bristol-Myers/Pfizer's Eliquis Encourages in VTE Analysis - Analyst Blog 6:50 p.m. Sept. 2, 2014 - Zacks.com
Biotechnology, Oil And Brazil ETFs To Watch This Week 9:05 a.m. Sept. 2, 2014 - Benzinga.com
Regeneron Pharmaceuticals' Pipeline Progress Raises Costs - Analyst Blog 6:30 p.m. Aug. 29, 2014 - Zacks.com
4 Biotechs That Might Be Bought Soon 10:53 a.m. Aug. 29, 2014 - Investors Business Daily
Today's Market: Red Hot Biotech And Big Pharma Names To Watch 8:22 a.m. Aug. 29, 2014 - Seeking Alpha
Bristol-Myers' Oral HCV Treatment Daklinza Gets EU Clearance - Analyst Blog 6:50 p.m. Aug. 28, 2014 - Zacks.com
#PreMarket Primer: Thursday, August 28: Russia Implicated Further In Ukrainian Conflict 6:00 a.m. Aug. 28, 2014 - benzinga.com
Biotech Stock Roundup: Biotechs Surge on InterMune Acquisition Deal, Focus on More M&As - Analyst Blog 10:32 a.m. Aug. 27, 2014 - Zacks.com
Rising Short Interest in Biotech Stocks 9:42 a.m. Aug. 27, 2014 - 247WallSt.com
Celgene, Gilead Lead Big Biotech Stock Movers 1:38 p.m. Aug. 26, 2014 - Investors Business Daily
Stock Market News for August 26, 2014 - Market News 10:10 a.m. Aug. 26, 2014 - Zacks.com
Why Celgene Stock Is Still A Good Investment Opportunity 9:05 a.m. Aug. 26, 2014 - Seeking Alpha
Pfizer, Merck Team Up on Cancer Study 8:42 a.m. Aug. 26, 2014 - The Wall Street Journal Interactive Edition
Biogen, Celgene In Buy Range; LinkedIn Coming Back 5:43 p.m. Aug. 25, 2014 - Investors Business Daily
Majority Of IBD 50 Firms Strong On Sponsorship 5:37 p.m. Aug. 22, 2014 - Investors Business Daily
Majority Of IBD 50 Firms Strong On Sponsorship 5:37 p.m. Aug. 22, 2014 - Investors Business Daily

Technical Data on Biotech Stocks - ARIAD Pharma, Tekmira Pharma, Arrowhead Research, Celgene, and Amgen 8:55 a.m. Today - PR Newswire - PRF
Phase III FIRST™ (MM-020/IFM 07-01) Trial of REVLIMID® (lenalidomide) Plus Dexamethasone in Newly Diagnosed Multiple Myeloma Patients Who Are Not Candidates for Stem Cell Transplant Published in New England Journal of Medicine 7:31 a.m. Today - BusinessWire - BZX
VentiRx Pharmaceuticals Provides Corporate and Clinical Update 8:00 a.m. Sept. 2, 2014 - PR Newswire - PRF
Upcoming Conferences Schedule, Clinical Trial Data Release Schedule, Milestone Payment, and Expansion of Partnership - Research Reports on Celgene, Actavis, Regeneron, ISIS and UnitedHealth 9:10 a.m. Aug. 29, 2014 - PR Newswire - PRF
Acquisitions, Clinical Study Results, Dividends, and Technical Updates - Research Reports on Mallinckrodt, Celgene, Actavis, UnitedHealth and Bristol-Myers 8:50 a.m. Aug. 21, 2014 - PR Newswire - PRF
Celgene Corporation to Present at Investor Conferences in September 8:30 a.m. Aug. 21, 2014 - BusinessWire - BZX
Bristol-Myers Squibb and Celgene Enter Clinical Collaboration Agreement to Evaluate Immunotherapy and Chemotherapy Combination Regimen 8:00 a.m. Aug. 20, 2014 - BusinessWire - BZX
Clinical Study in the Journal of Clinical Oncology Reports Patients with Diffuse Large B-Cell Lymphoma Receiving Oral REVLIMID with Standard R-CHOP Achieved 98% Overall Response Rate and 80% Complete Response Rate 7:30 a.m. Aug. 19, 2014 - BusinessWire - BZX
Collaborations, Financial Results, and Technical Updates - Research Reports on Actavis, UnitedHealth, Bristol-Myers Squibb, Celgene and Aetna 8:40 a.m. Aug. 12, 2014 - PR Newswire - PRF
Critical Alerts For Advanced Micro Devices, Celgene, Weibo, SunPower, and Time Warner Released By InvestorsObserver 9:31 a.m. Aug. 5, 2014 - PR Newswire - PRF
Celgene Reports Results from the Phase III POSTURE Study Evaluating Oral OTEZLA® in Ankylosing Spondylitis 7:00 a.m. July 9, 2014 - BusinessWire - BZX
Biotech Stocks Highlight -- Research on Celgene, Inovio Pharma, Amgen, and Array BioPharma 6:40 a.m. July 9, 2014 - PR Newswire - PRF
Clinical Trials, Petitions, and Upcoming Earnings Releases - Analyst Notes on Celgene, Covidien, AbbVie, Teva and Thermo Fisher Scientific 5:40 a.m. July 8, 2014 - PR Newswire - PRF
Celgene Corporation to Announce Second Quarter 2014 Results on July 24, 2014 8:31 a.m. July 1, 2014 - BusinessWire - BZX
CORRECTING and REPLACINGCelgene Corporation Mourns the Passing of Board of Director Member, Rodman L. Drake 2:28 p.m. June 26, 2014 - BusinessWire - BZX
Companies Chasing Gold Nugget of Immuno-Oncology Like Never Before 9:37 a.m. June 26, 2014 - ACCESSWIRE
Celgene Corporation Mourns the Passing of Board of Director Member, Rodman L. Drake 8:30 a.m. June 26, 2014 - BusinessWire - BZX
Celgene Stockholders Approve Two-for-One Stock Split 8:30 a.m. June 19, 2014 - BusinessWire - BZX
Results from Phase III Study (AML-001) of VIDAZA® (Azacitidine for Injection) in Acute Myeloid Leukemia Presented at EHA 8:58 a.m. June 14, 2014 - BusinessWire - BZX
Studies Presented at 19th European Hematology Association Annual Congress Evaluate Activin Receptor Ligand Trap Programs in Beta-Thalassemia 3:00 a.m. June 14, 2014 - BusinessWire - BZX

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

EClinCloud Targets Better FDA Compliance with AI Boost

FDA Citations Under the Microscope Here we are, wading through another layer of clinical research nitty-gritty, and it's bringing clinical processes under a sharper lens. EClinCloud just dropped a hefty analysis on 1,715 FDA Bioresearch Monitoring citations. Turns out, protocol compliance, informed consent, and case histories chew up 46.2% of these citations. Sounds like...

Vanity Fair Lingerie Reveals New Smoothing Bra

A Bra Revolution or Just Another Launch? I'll admit it, lingerie isn't the usual breakfast discussion for me, but Vanity Fair Lingerie's move with their new Flawlessly Smooth™ Bra piqued my interest. Announced in Bowling Green, Kentucky, on November 2, 2026, and set against the lavish backdrop of an upcoming New York City event cohosted by Cosmopolitan, it's less about...

Navigating New Home Builds: Tucson’s Precise Timelines

Building a Home in Tucson: Timing is Everything Ask anyone who's ever dreamed of their own custom-built home—patience isn't just a virtue, it's a necessity. In Tucson, Arizona, where the landscape is as captivating as it is challenging, Home Remodeling Expert Robin Hartman breaks down exactly what homeowners should expect when embarking on a home build. Hartman, through...

Northwood's $375M Boost: Satellite Network Expansion

Northwood's Bold Leap into Space Connectivity Here's a nugget of info that could jolt your morning coffee: Northwood Space Corp—yeah, the folks linking satellites to Earth—just pulled in a whopping $375 million in Series C funding. This ain't your average capital injection; it's a full-throttle push to broaden their ground network reach and revamp space...

Envision's 800V DC System Cuts the Powercake First

Envision Hits a Milestone in AI Power Dynamics You ever feel like the future is knocking on your door, but you've still got your headphones on? Well, Envision just kicked the door open with the world's first commercial deployment of an integrated 800-volt direct current (800V DC) power system in a large-scale AI data center. This technological marvel is now up and running...

Novartis Pulls the Plug on BioArctic Agreement

Novartis Drops BioArctic Like a Hot Potato Well, folks, it looks like Novartis has decided to pack up its bags and hightail it out of its collaboration with BioArctic AB. This ain't just any small piece of news—it's got ramifications that have folks in the biotech and healthcare sector scratching their heads and, probably, feeling a mixture of apprehension and...

NuvoAutoLinQ Transforms Device Connectivity Management

Leapfrogging the Connectivity Conundrum Picture this: you're staring at a payment terminal that's just as lifeless as your teenager's enthusiasm on a Monday morning. The signal's full bars, yet the device's not connecting. Classic story in the world of connected devices, right? Actually, no more. Enter NuvoLinQ with its snazzy new showcase: NuvoAutoLinQ. This tech...

Johns Hopkins Teams with Prospect HQ for Athlete Careers

Snagging a career after college isn't quite as easy as catching a football, but the folks over at Johns Hopkins University Athletics and Prospect HQ seem to think they have a playbook for it. You might raise an eyebrow hearing this, but Prospect HQ has now roped in student-athletes from over 500 colleges and universities nationwide into its talent pool. That's a hefty...

Discover Myrtle Beach's Festive Charm This Season

Uniquely Coastal Celebrations in Myrtle Beach Forget the snow, friends. Picture this: you’re swapping out cozy firesides for ocean breezes this holiday season. Down in Myrtle Beach, the holidays have a bit of a coastal twist. From the vibrant Boardwalk along the oceanfront to the historic charm of riverside Conway, this area is lighting up its 14 different communities...

YOUTOPIA Fashion Final Fuels Chinese Creative Growth

A Melting Pot of Chinese Creative Talent Under the neon glow of Shanghai’s iconic skylines, the 2026 YOUTOPIA Fashion Final became a buzzing hive of creative energy — the kind that prickles your skin and makes you lean in. This ain't just about strutting pretty threads; it's the crucible for tomorrow's fashion titans, the place where raw talent gets its first taste of...